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The glucocorticoid receptor (GR) exerts numerous functions in the body and brain. In the brain, it has
been implicated, amongst others, in feedback regulation of the hypothalamic-pituitary-adrenal axis, with
potential deﬁcits during aging and in depression. GRs are abundantly expressed in the hippocampus of
rodent, except for the Ammon’s horn (CA) 3 subregion. In rhesus monkey however, GR protein was
largely absent from all hippocampal subregions, which prompted us to investigate its distribution in
human hippocampus. After validation of antibody speciﬁcity, we investigated GRa protein distribution in
the postmortem hippocampus of 26 human control subjects (1e98 years of age) and quantiﬁed changes
with age and sex. In contrast to monkey, abundant GR-immunoreactivity was present in nuclei of almost
all neurons of the hippocampal CA subﬁelds and dentate gyrus (DG), although neurons of the CA3
subregion displayed lower levels of immunoreactivity. Colocalization with glial ﬁbrillary acidic protein
conﬁrmed that GR was additionally expressed in approximately 50% of the astrocytes in the CA regions,
with lower levels of colocalization (approximately 20%) in the DG. With increased age, GR expression
remained stable in the CA regions in both sexes, whereas a signiﬁcant negative correlation was found
with age only in the DG of females. Thus, in contrast to the very low levels previously reported in
monkey, GR protein is prominently expressed in human hippocampus, indicating that this region can
form an important target for corticosteroid effects in human.
 2013 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Glucocorticoid hormones (GCs) are important mediators of
the stress response in mammals, including humans. Exposure to
a stressor triggers activation of corticotropin-releasing hormone
(CRH) neurons in the paraventricular nucleus (PVN) of the hypo-
thalamus, which eventually induces GC release from the adrenal
gland. GCs are highly lipophylic transcription factors that exert
numerous effects on metabolism, inﬂammation, and cognition (de
Kloet et al., 2005). When in the circulation, GCs exert negative
feedback inhibition on the same regions that triggered their initialSILS-Center forNeuroscience,
l.: þ31 20 525 7631; fax:þ31
evier OA license.release (i.e., the hypothalamus and pituitary), and they also inﬂu-
ence behavioral adaptation. These latter effects are generally
thought to be mediated, at least partly, through the low afﬁnity
glucocorticoid receptor (GR) that is abundantly expressed in the
hippocampus of rodents (Reul and de Kloet, 1985). The hippo-
campal formation is a key limbic region that participates in spatial
navigation and the modulation of cognition, mood, and behavior
(de Kloet et al., 2005). Based on the presence of GR and the results
from various pharmacological studies it has been postulated that
the hippocampus is an area in which GCs act to modulate behavior
and hypothalamo-pituitary-adrenal (HPA) axis activity (Jacobson
and Sapolsky, 1991; Juruena et al., 2006; Sapolsky et al., 1984).
The GR is a member of the nuclear hormone receptor super-
family of ligand-activated transcription factors. After ligand
binding, the hormone receptor complex translocates from the
cytoplasm to the nucleus where it inﬂuences gene transcription.
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stress levels of GCs, and helps to maintain GC levels within speciﬁc
limits (Erdmann et al., 2008; Kretz et al., 1999). Aberrant GR
expression has been implicated in stress resistance, anxiety, and
depression (Alt et al., 2010; de Kloet et al., 2005; Ridder et al., 2005;
Wang et al., 2012; Wei et al., 2007). In humans, there is a consid-
erably diversity of GR transcripts and isoforms (Sinclair et al. 2011),
which includes 13 exon 1messenger RNAvariants and 8 N-terminal
variants, which arise from the predominant GR isoform, GRa, that
differ in size from 94 to 54 kDa based on the location of their
translation start site.
The regional distribution of the GR protein in the hippocampus
has been studied before in various species. In rodents, GR expres-
sion is ubiquitous throughout the brain and enriched in key regions
of the HPA axis and the hippocampus, and GR is abundantly
expressed in the CA pyramidal cell layer and in the granule cell layer
of the dentate gyrus (DG), with generally lower levels in the CA3
subregion (Morimoto et al., 1996; Sarabdjitsingh et al., 2010).
In contrast to this well-established distribution in rodent brain,
distribution of GR protein in the primate hippocampus is poorly
studied. To date, there are no detailed studies of regional protein
expression of the GR in the human hippocampus. In rhesusmonkey,
a general absence of GR was reported in themain neuronal layers of
the hippocampal formation, and astroglia did express GR (Sanchez
et al., 2000). Because this suggested a species difference in GR ex-
pression, we set out to study GR protein distribution in the human
hippocampus and hypothalamus.
To validate our antibody and address the inﬂuence of post-
mortem delay on GR expression, we studied a series of postmortem
rat brains, performed antigen preadsorption and Western blot, and
studied GR coexpression in CRH-containing parvocellular neurons
of the human hypothalamic PVN, an important nucleus forTable 1
Clinicopathological data of the human control cases
Brain number Age (y) Sex PMD (h:min) pH Brain reg
93-006 1 M 5:30 NA Hippoca
B.A 2 F 12:00 NA Hippoca
B 2 F 18:00 NA Hippoca
G.D 3 F 24:00 NA Hippoca
P 8 F 8:00 NA Hippoca
F.A 11 F 6:00 NA Hippoca
00-141 20 F 8:45 6.50 Hippoca
97-159 48 M 5:30 6.88 Hippoca
05-034 56 M 14:00 7.03 Hippoca
05-068 56 M 9:15 6.54 Hippoca
98-127 56 M 5:25 6.55 Hippoca
90-065 57 M 4:25 8.05 Hippoca
01-004 64 F 8:35 6.40 Hippoca
97-042 65 F 12:50 6.94 Hippoca
06-037 66 M 7:45 6.70 Hippoca
03-054 67 M 4:30 NA Hippoca
04-015 69 F 4:20 6.12 Hippoca
95-072 75 M 7:15 6.33 Hippoca
03-013 82 F 11:30 6.77 Hippoca
07-007 84 M 5:35 6.98 Hippoca
05-017 87 M 10:20 6.32 Hippoca
96-078 87 F 8:00 6.91 Hippoca
93-035 89 F 4:20 6.68 Hippoca
01-006 91 F 5:45 6.49 Hippoca
05-063 93 F 4:00 6.64 Hippoca
00-027 98 M 8:40 6.66 Hippoca
96-411 49 M 19:00 NA Hypotha
98-200 46 F 11:00 NA Hypotha
S09-015a 73 M 6:00 PMD Hippoca
S09-061a 72 F 7:00 PMD Hippoca
T08-16837a 28 F 0:00 Surgical Cortex
T09-1122a 35 F 0:00 Surgical Cortex
Key: NA, unknown or not available; PMD, postmortem delay.
a Frozen human tissue.GR-mediated feedback inhibition, that also expresses vasopressin,
and is involved in HPA feedback inhibition, and as such, is expected
to at least express signiﬁcant levels of GR protein (Erkut et al., 1998;
Han et al., 2005; Kretz et al., 1999; Lucassen et al., 1994; Uht et al.,
1988; Wang et al., 2008). We next questioned whether GR
expression in the human hippocampus is comparable with the
distribution in the rodent or primate hippocampus. Third, consid-
ering the numerous reports on changes with age (Bao and Swaab,
2007; Bizon et al., 2001; Hassan et al., 1999; Mizoguchi et al.,
2009; Murphy et al., 2002; Perlman et al., 2007; Raadsheer et al.,
1993; Sinclair et al., 2011; van Eekelen et al., 1992), we investi-
gated whether age- and sex-related changes in GR protein occur in
a cohort of 26 control subjects ranging from 1 to 98 years of age.
2. Methods
2.1. Human brain tissue
Postmortem human brain tissue used in this study was obtained
from the Netherlands Brain Bank (NBB) and written permissionwas
obtained from the patients or the next of kin for all brain autopsies
and for the use of the tissues and clinical data for research purposes.
Twenty-six subjects were studied, 12 male and 14 female, ranging
in age from 1 to 98 years. Clinicopathological details on disease
condition, cause of death, pH of cerebrospinal ﬂuid, and post-
mortem delay (PMD) are given in Table 1.
The hippocampus proper was dissected at autopsy, ﬁxed in
formalin for 1e2 months, dehydrated, embedded in parafﬁn, and
serially sectioned at 8 mm. Midlevel sections of each subject were
used for immunohistochemistry for GR. To study whether GR-
immunoreactivity (ir) is distributed in a homogenous way along
the septotemporal axis, 3 groups of 4 additional patients wereion Cause of death Medication
mpus Unclear; possible viral encephalitis NA
mpus Wilms tumor NA
mpus Pneumonia, sepsis NA
mpus Cardiorespiratory insufﬁciency NA
mpus Acute lymphoid leukemia NA
mpus Acute lymphoid leukemia NA
mpus Sudden death NA
mpus Legal euthanasia Midazolam
mpus Terminal congestive heart failure NA
mpus Myocardial infarction Domperidone
mpus Myocardial infarction Ceftriaxone
mpus Myocardial infarction NA
mpus Myocardial infarction Tramadol
mpus Myocardial infarction Adrenaline
mpus Ruptured abdominal aneurysm aorta Testosteron
mpus Cardiac shock/multiple organ failure Insulin
mpus Cardial decompensation NA
mpus Myocardial infarction Digoxine
mpus Congestive cardiac failure Trimethoprim
mpus Myocardial infarction Midazolam, morphine
mpus Pneumonia, heart failure NA
mpus Myocardial infarction Codeine
mpus Myocardial infarction Morphine
mpus Sudden death Morphine, digoxine
mpus Myocardial infarction Midazolam, morphine
mpus Cardiac tamponade NA
lamus Cardio-pulmonal insufﬁciency NA
lamus NA NA
mpus Myocardial infarction NA
mpus Broncopneumonia/myocardial infarction NA
Temporal lobe epilepsy NA
Temporal lobe epilepsy NA
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and compared (see Supplementary Fig. 1 and Table 1). To further
investigate the distribution of GR in astroglia, a series of sections
from 4 additional conﬁrmed control subjects were used for
immunohistochemical double staining of GR and glial ﬁbrillary
acidic protein (GFAP). For the analysis of GR and its coexpression in
CRH neurons, additional hypothalamic tissue (6 mm) was used of 2
conﬁrmed control cases obtained from the NBB (Table 1). Two
freshly frozen cortices and 2 frozen hippocampi were further ob-
tained from the Department Neuropathology of the Academic
Medical Center (University of Amsterdam) and used for Western
blot analysis to conﬁrm speciﬁcity of the GR antibody (Table 1).
Extensive clinicopathological investigation at the Department of
Neuropathology had conﬁrmed their control status.
2.2. Methodological optimization; inﬂuence of PMD on rat GR
immunohistochemistry
For human brain, possible effects of PMD need to be taken into
account, not only with respect to total GR expression levels per se
that might be subject to protein breakdown, but also regarding
differences in the intracellular distribution of nuclear receptors
between cytoplasm and nucleus, as was for example, found under
conditions of glucocorticoid absence or after artiﬁcial PMDs (Fodor
et al., 2002; Nishi and Kawata, 2007; Visser et al., 1996). We
therefore studied in 3-month-old Sprague-Dawley rats the effect of
different postmortem times on GR expression in 6 brains that were
kept at RT for 0, 3, and 6 hours after death before dissection of the
brain and immersion ﬁxation in formalin for 7 days. The PMD rat
brains were then processed at the NBB and embedded in parafﬁn
using the exact same embedding protocol as used for the human
PMD brain tissue in this study.
Eight micrometer thick parafﬁn sections were cut and a well-
characterized rat GR antibody (Morimoto et al., 1996) was used
to study GR in these PMD rat studies. Mounted rat hippocam-
pal sections were deparafﬁnized, rehydrated, and placed in
a conventional microwave oven (Miele) in citrate buffer (0.01 M,
pH 9.0) for 20 minutes for antigen retrieval. After cooling down for
30 minutes, sections were incubated in 0.3% H2O2 in methanol for
30 minutes to block endogeneous peroxidase activity. After
washing in Tris buffered saline (TBS; 0.05 M Tris and 0.15 M NaCl,
pH 7.6), the rat hippocampal sections were incubated in the
primary GR antiserum for 1 hour at room temperature (RT), fol-
lowed by an overnight incubation at 4 C. Antiserum was diluted
in Supermix (0.05 M TBS buffer containing 0.5% Triton-X and
0.25% gelatin, pH 7.6) at a concentration of 1:2000. After rinsing in
TBS, sections were incubated in a 1:200 dilution of biotinylated
goat anti-rabbit IgG (Vector Laboratories) in Supermix for 1 hour
at RT. After rinsing in TBS, sections were incubated in a 1:800
dilution of streptavidin-biotin-peroxidase complex (Vectastain
ABC Elite kit; Vector Laboratories) in Supermix for 1 hour at RT.
After rinsing in TBS and incubation in 3,3-diaminobenzidine
(DAB)-ammonium nickel solution (0.5 mg/mL DAB, 0.01% H2O2,
2.33 mg/mL nickel ammonium sulfate in TBS) at RT for 10 minutes,
the sections were rinsed in TBS, dehydrated, and coverslipped
with Entallan (Merck).
2.3. Human GR antibody validation
Considering the discrepancy between the GR pattern in rat and
primate, we choose to use the same antibody as had been used
before in the study on GR in the rhesus monkey (Sanchez et al.,
2000) (i.e., the afﬁnity puriﬁed rabbit polyclonal GR antiserum;
E-20, human GR, Santa Cruz Biotechnologies), that was directed
against the N-terminus of the classic human GRa protein and hasbeen used and validated in various previous reports (Lu et al.,
2006; Vancurova et al., 2001). Preadsorption, omission of the
ﬁrst antibody and Western blot on human brain tissue was per-
formed to conﬁrm its speciﬁcity. Two pieces of control cortex and 2
control hippocampi from 4 different patients were homogenized in
lysis buffer containing 10 mM Tris (pH 8.0), 150 mM NaCl, 10%
glycerol, 1% Nonidet P-40 (NP-40), 0.4 mg/mL Na-orthevanadate,
5 mM ethylenediaminetetraacetic acid (EDTA) (pH 8.0), 5 mM
NaF, and protease inhibitors (cocktail tablets, Roche Diagnostics,
Mannheim, Germany). Protein content was determined using
the bicinchoninic acid method. For electrophoresis, equal amount
of proteins (50 ug per lane) were separated by sodium
dodecylsulfate-polyacrylamide gel electrophoretic analysis (10%
acrylamide). Separated proteins were transferred to nitrocellulose
paper by electroblotting for 1 hour and 30 minutes (BioRad,
Transblot SD, Hercules, CA, USA). After blocking for 1 hour in 20
mM Tris, 150 mM NaCl, 1% Tween, pH 7.5 (TBST )/5% nonfat dry
milk, blots were incubated overnight at 4 C with the GR antibody
(1:1000). After several washes in TBST, the membranes were
incubated in TBST/5% nonfat dry milk, containing horseradish
peroxidase (HRP)-labeled goat anti-rabbit (Dako; 1:2500) for 1
hour at RT. Ir was visualized using Lumi-light PLUS Western blot-
ting substrate (Roche Diagnostics) and digitized using a Lumines-
cent Image Analyzer (LAS-3000, Fuji Film).
2.4. Immunohistochemistry for human GR
Mounted hippocampal sections were deparafﬁnized in xylene,
rehydrated in graded ethanol, and placed in a glass jar with citrate
buffer (0.01M, pH 6.0) that was positioned inside a kitchen steamer
device (Braun FS20). To unmask hidden antigens because of for-
malin ﬁxation, this steamer was ﬁlled with distilled water and
sections were heated at full power for 1 hour. After cooling down
for another 30minutes, the sections were incubated in 0.3% H2O2 in
methanol for 30 minutes to block endogenous peroxidase activity.
After washing in TBS, the primary antiserum was added to the
sections for 1 hour at RT, followed by an overnight incubation at
4 C. Antiserum was diluted in supermix at a concentration of
1:1000. After retrieving the primary antibody and rinsing in TBS,
sections were incubated in a 1:200 dilution of biotinylated goat
anti-rabbit IgG in Supermix for 1 hour at RT. Signal was further
ampliﬁed by a second incubation with the retrieved primary anti-
body and goat anti-rabbit IgG both for 1 hour at RT. After rinsing
in TBS, sections were incubated in a 1:800 dilution of streptavidin-
biotin-peroxidase complex (ABC Elite, Vector Laboratories) in
Supermix for 1 hour at RT. After washing in TBS, sections were
incubated in Tyramide in TBS (1:750 Tyramide in TBS, 0.01% H2O2;
a generous gift from Dr I. Huitinga, NBB Amsterdam) for 30 minutes
at RT. After washing in TBS, sections were again incubated in 1:800
dilution of streptavidin-peroxidase complex in Supermix for
45 minutes at RT. The sections were then rinsed in TBS and incu-
bated in DAB-nickel solution at RT for 40 minutes, rinsed in TBS,
dehydrated, cleared in xylene, and coverslipped.
Additional speciﬁcity tests consisted of: (1) omission of the ﬁrst
antibody; and (2) preadsorption of the primary antisera with the
corresponding GR peptide antigen (sc-1003 P, Santa Cruz). Pre-
adsorption of the ﬁrst antiserum was at 1:100 according to stan-
dard procedures. Brieﬂy, after coating nitrocellulose (NC) paper
(3MM;Whatman) in 2% gelatin solution at 40 C in a water bath for
1 hour, the NC paper was dried overnight. One mL of a peptide
dilution series made in 10% glycerol (100%) plus 10% dime-
thylformamide (100%) plus 2.5% Nonidet (100%) medium was
spotted on gelatin-coated NC that was left to dry for 1 hour.
Whatman 3MM paper was then incubated in freshly made buff-
ered 4% paraformaldehyde (pH 7.6) for 5 minutes and dried. The
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spotted proteins on the NC by placing it in a press block (paraﬁlm
plus NC plus ﬁlter paper containing ﬁxative plus paraﬁlm) over-
night. After washing the NC in H2O, 0.05 M Tris/HCl (3.03 g Tris plus
500 mL aqua dest, pH 7.6), and supermix, the NC sheet was then
incubated in the antibody solution for 4 hours (RT). The antibody
solution was re-collected and then used as ﬁrst antibody for
immunocytochemistry.
2.5. Immunoﬂuorescent double staining for GR and CRH
Because glucocorticoid feedback of the HPA axis is known to
occur to a large extent at the level of the parvocellular CRH neurons
located in the hypothalamic PVN (Kretz et al., 1999), these neurons
are expected to at least express signiﬁcant amounts of GR (Han
et al., 2005) and a double immunoﬂuorescent staining protocol
for CRH and GR was therefore developed. Double staining for GR
and CRH was performed on sections located approximately in the
middle of the PVN region of 2 established control subjects of 46 and
49 years of age; patient numbers 96-411 and 98-200 (Table 1). The
sections weremounted on Super-Frost/Plus (Menzel) slides and air-
dried. After deparafﬁnization and rehydration in graded ethanols,
the hypothalamic sections, similar to the hippocampal GR protocol,
were placed in citrate buffer (0.01 M, pH 6.0) and heated in the
steamer for 1 hour. After cooling down for another 30 minutes,
sections were coincubated with antibodies against GR (E-20) and
CRH (PFU-83), diluted in Supermix at 1:250 and 1:5000, respec-
tively, for 1 hour at RT and overnight at 4 C. The CRH (PFU-83)
antibody is directed against the extreme C-terminal part (amino
acids 38e39) of corticotropin-releasing factor (CRF), has been
characterized extensively before (de Goeij et al., 1992; van Oers
et al., 1989) and has been used before on human hypothalamic
sections as well (Erkut et al., 1998; Raadsheer et al., 1993). After
washing in TBS, sections were incubated with the ﬂuorescent
secondary antibody Alexa 488 anti-rat (1:400) and Alexa 594 anti-
rabbit (1:400) for 4 hours at RT before rinsing in TBS. Sections were
coverslippedwith glycerin and viewed under a regular ﬂuorescence
microscope (model E800; Nikon, Tokyo, Japan) and photographed
on a confocal laser scanning microscope (model LSM510; Carl Zeiss,
Oberkochen, Germany). For identifying the parvocellular and the
magnocellular neurons of the PVN in the hypothalamus, the human
hypothalamus has no speciﬁc subregions where CRH neurons are
concentrated, as in rat (Kiss et al., 1991), but because CRH-positive
parvocelllular neurons are distributed throughout the human PVN
(Raadsheer et al., 1993) we used, aside from CRH ir, morphologic
and size criteria to distinguish magnocellular from parvocellular
neurons.
2.6. Double immunocytochemical staining for human GR and the
astrocyte marker GFAP
Double staining for GR and GFAP protein was performed at
light microscopical level in order to investigate the presence and
subregional hippocampal distribution of the GR in astrocytes. After
immunocytochemical detection of GR using DAB with ammonium-
nickel ampliﬁcation, yielding a black precipitate, the sections were
subsequently incubated with an antibody directed against GFAP
(pan-GFAP; Dako) in Supermix at concentration of 1:1000 for
1 hour at RTand then overnight at 4 C. After rinsing in TBS, sections
were incubated in biotinylated goat anti rabbit IgG (1:200) in
Supermix for 1 hour at RT, washed in TBS before signal ampliﬁca-
tion with ABC at a 1:800 dilution in Supermix for 1 hour at RT.
Sections were developed in DAB solution at RT for 10 minutes,
yielding a brown precipitate, rinsed in TBS, dehydrated, cleared in
xylene, and coverslipped.For quantiﬁcation, 3 microscopic ﬁelds corresponding to a 40
magniﬁcation were placed over the subregion of interest and the
number of astrocytes counted and the percentage of cells coex-
pressing GR and GFAP determined.
2.7. Image analysis and quantiﬁcation
Immunocytochemical signal was quantiﬁed using image anal-
ysis tools described before in detail (Ishunina et al., 2003; Ishunina
et al., 2005). Measurements were performed using an IBAS-KAT
image analysis system (Kontron KAT-based system). The image
analysis systemwas connected to a SONY XC-77CE black and white
CCD camera mounted on a Zeiss microscope. Sampling and area
selection of the hippocampus were performed as follows; in each
hippocampal section to be analyzed, an area including the CA and
DG subregion (using the 20 objective of the microscope) was
loaded into the IBAS and displayed on the image analysis monitor.
The position of the section under the microscope was stored using
the xey coordinates of the scanning stage. In this image, the
contour of the CA1, CA3, or DGwas outlinedmanually. To determine
the amount of DAB-Ni precipitate corresponding to GR ir, pictures
were ﬁrst collected of the hippocampus taken atmagniﬁcation 20.
The contours of the different hippocampal subregions are then
outlinedmanually, based on the atlas of the human hippocampus of
Duvernoy. Within each contour, a thresholding procedure is used to
select only those pixels that contain DAB-Nickel precipitate, cor-
responding to GR ir. The threshold of themask is set by the observer
at minimal 3.5 background level in such a way that it covers only
the immunopositive pixels within the outlined area of the contour.
Of the pixels within this mask, the computer then determines
optical density (OD) and the percentage of surface area covered by
GR-ir signal (PSA) for each subregion, per patient which was then
correlated with age and sex. The thresholding procedure assures
that background or other surface areas not covered by GR signal are
excluded from the quantiﬁcation. This procedure has also been
applied for comparable analyses before (Ishunina et al., 2007).
Because the data are presented as densities, they reﬂect changes in
total amount of GR protein to the extent that the volumes of these
regions do not change in volume. Statistical analysis was conducted
with SPSS (SPSS statistical software version 20). The differences
between the groups were statistically evaluated using analysis of
variance. Spearman correlation was used to analyze the correlation
of GR-ir with age. Values of p < 0.05 were considered signiﬁcant.
3. Results
3.1. Methodological optimization; validation of human GR antibody
speciﬁcity
Western blot with human anti-GR antiserum (E-20) performed
on samples from freshly-frozen biopsy human cortical tissue
revealed a single band corresponding with the expected height of
the GRa (Fig. 1A) (Han et al., 2005; Sinclair et al., 2011).
No GR-ir was observed in any of the human hypothalamic or
hippocampal sections after omission of the primary antiserum
(not shown), though preadsorption of the primary antisera with the
corresponding peptide antigen used to generate the antibody
(sc-1003 P; Santa Cruz), completely abolished all GR-ir in the human
hippocampus (Fig. 1B) indicating speciﬁcity of the E-20 antibody.
3.2. Inﬂuence of PMD on GR levels
In parafﬁn sections of the rat brain tissue that was rapidly
immersion ﬁxed after a PMD of 0 hours, prominent ir for GR was
found in almost all neuronal nuclei of the hippocampus (Fig. 2).
Fig. 1. (A) Western blot of freshly-frozen human cortical tissue. (B) Results of the preadsorption test. Abbreviation: DG, dentate gyrus; GR, glucocorticoid receptor.
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1996), abundant GR-ir was present in the neuronal layers of the
CA1 and DG and in hilar cells, but not in some neurons of the CA3
subregion (arrowhead in Fig. 2), that was largely devoid of any GR
staining. Although GR-ir was present in small astrocytes, its distri-
bution in neurons was largely nuclear throughout the main subre-
gions and no GR-ir was observed in the cytoplasm.
This pattern did not change when tissues were ﬁxed after PMDs
of 3 and 6 hours respectively (Fig. 2). Nuclear GR-ir after such PMDs
remained present at similar densities throughout the DG and
CA neuronal layers. There were no obvious differences in nuclear
staining intensity when compared with the PMD 0-hour time point,
nor did any cytoplasmic staining appear with increasing PMDs
(3 and 6 hours) in either of the subregions, indicating a pronouncedstability of GR protein with increasing PMDs, that was relevant for
the present human cohort.
3.3. GR immunohistochemistry in human hypothalamus
To further conﬁrm antibody speciﬁcity, we assessed whether
parvocellular CRH neurons in the human hypothalamic PVN coex-
press GR. Double immunoﬂuorescent staining for GR and CRH was
performed on hypothalamic sections containing the PVN region of
established cases.
In the human hypothalamic sections, nuclear GR expressionwas
seen throughout the main hypothalamic nuclei, such as the peri-
ventricular nucleus of the ventral zone, the diagonal band of Broca,
the nucleus basalis of Meynert, and parts of the bed nucleus of the
Fig. 2. (AeC) Photomicrograph of glucocorticoid receptor (GR) staining in the postmortem rat hippocampus. No changes are seen with increasing postmortem delays (PMDs) at
3 (B) or 6 (C) hours. (D) Overview of the human hippocampus of a patient with a PMD of 8 hours. Abundant GR-immunoreactivity (ir) is present throughout the CA and dentate
gyrus (DG) subregions. (E) Detail of the DG. (F) Detail of the CA1. Arrow indicates the nuclear GR-ir pattern present in almost all CA and DG neurons. (G) Detail of the CA3 subregion
where nuclear neuronal signal (arrow) is present but where also nonstained neuronal nuclei (arrowhead) are seen. (HeJ) Double staining for GR (black) in neuronal nuclei and glial
ﬁbrillary acidic protein (GFAP)-ir astrocytes (brown) in the hilar area (H), in the CA1 subregion (I) and in the associated cortex (J). Arrow indicates a GR positive nucleus in a GFAP-
positive astrocyte. Arrowhead indicates a astrocyte without any GR-ir in its nucleus. Bar indicates 30 um. (K) Detail of a CA3 neuron showing nuclear GR-ir adjacent to a nonstained
neuron (arrow). Bar indicates 20 um.
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of the supraoptic nucleus and PVN (Fig. 3). In the supraoptic nucleus,
GR-ir was generally found in neuronal nuclei. In the PVN, GR-ir was
particularly detected in small neurons that coexpressed CRH ir
(Fig. 4). Taken together with the data from theWestern blot and the
preadsorption test, this conﬁrmed speciﬁcity of the E-20 antibody.
3.4. GR immunohistochemistry in human hippocampus
In the human hippocampus, GR-ir was observed as a prominent
pattern of expression throughout the pyramidal and granule layers
(Fig. 2). Strong nuclear staining was present in DG and CA neurons,
and in the CA3 subregion, although the latter region displayed
a more sparse distribution and occasionally neurons without GR-ir
nuclei were present here as well, similar to the distribution in
rodent brain. In the DG, intense nuclear GR-ir was present in almost
all granule cells that were densely packed together, whereas the
CA1 neurons were more dispersed. This pattern was conﬁrmed by
quantiﬁcation of the optical density and surface area covered by
GR-ir. Thus, when comparing the different hippocampal subregionsFig. 3. (A) Low power photomicrograph of glucocorticoid receptor (GR) immunoreactivity (ir
level of the supraoptic nucleus SON. (C) Enlargement of the SON. Several neurons of appare
(arrow). (D) Enlargement of the PVN; large, magnocellular neurons without nuclear GR sign
(arrowheads). Bar indicates 25 um. (E) Further enlargement of the human PVN showing exam
in a neighboring magnocellular neuron (arrow, lower left corner). Bar indicates 20 um. Abbfor GR-ir by using analysis of variance, a signiﬁcant difference was
found in OD of the GR signal between CA3 and DG (p < 0.01) and
between CA1 and DG (p < 0.01), but not between CA1 and CA3
(p ¼ 0.253). For PSA of GR-ir, signiﬁcant differences were found
between CA1 and CA3 (p < 0.01); CA1 and DG (p < 0.01) and
between CA3 and DG (p < 0.01) corresponding to different package
densities. Because the present quantiﬁcation was performed at the
midlevel, we speciﬁcally compared different additional anatomic
levels (4 patients at a more rostral and 4 at a more caudal level) but
did not ﬁnd major differences from the values reported when
sampled at the hippocampal midlevel (see Supplementary Fig. 1
and Supplementary Table 1).
Colocalization with the astrocyte marker GFAP conﬁrmed that
GR was not only conﬁned to the neuronal population, but also
expressed in a subset of astroglia (Fig. 2). Quantiﬁcation of the
percentage of double staining in CA1, CA3, hilus, and cortex of
human brain sections revealed that approximately 50% of the
astrocytes in these regions express GR, a percentage that is lower in
the DG where approximately 20% of the GFAP positive astrocytes
coexpress GR.) in the human hypothalamus taken at the level of the PVN. (B) Low power taken at the
ntly similar sizes are seen with nuclear GR immunostaining (arrowhead) and without
al are observed (arrows) and smaller, parvocellular neurons with GR-ir in the nucleus
ples of nuclear signal in parvocellular cells (arrowheads) and the absence of GR signal
reviations: III, third ventricle; PVN, paraventricular nucleus; SON, supraoptic nucleus.
Fig. 4. Double immunoﬂuorescent labeling for glucocorticoid receptor (GR) and corticotropin-releasing hormone (CRH). (A) Low power of the human PVN. Arrows indicate
examples of parvocellular neurons showing clear double-immunoﬂuorescence for CRH (green) and GR (red). (B) High power of 2 double-stained cells for CRH (green) and GR (red)
(arrow). Bar represents 20 um. (C) Three cells showing double immunoﬂuorescence for CRH and GR (arrow), 1 of which only shows GR-immunoreactivity (ir) (arrowhead).
(D) Examples of 2 double-stained parvocellular neurons (arrow) next to a magnocellular neuron (asterisk) that is only GR-ir (arrowhead) and fails to show CRH coexpression. White
arrows on top of the photomicrograph indicate the obvious differences in size between the magnocellular and parvocellular neurons (left side). Abbreviation: III, third ventricle.
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Testing our cohort for correlations between GR expression with
PMDoragerevealed that thegroupsofmale and femaledidnotdiffer
signiﬁcantly in these parameters (age, p ¼ 0.77; PMD, p ¼ 0.35). In
addition, correlating (1) OD and (2) percentage of surface area
covered by GR-ir signal (PSA) with the PMDs of all subjects, revealed
no signiﬁcant correlation for these parameters in either of the
subregions (OD: CA1, p ¼ 0.413; CA3, p ¼ 0.251; DG, p ¼ 0.330; PSA:
CA1,p¼0.130; CA3,p¼0.584;DG,p¼0.104), conﬁrmingour rat data
also in human brain: that PMD does not affect GR-ir.
No signiﬁcant correlation was found for between age and GR-ir
in all subjects in either subregion (OD: CA1, p ¼ 0.348; CA3,
p ¼ 0.962; DG, p ¼ 0.171; PSA: CA1, p ¼ 0.069; CA3, p ¼ 0.081; DG,
p ¼ 0.086; see Fig. 5). Also, no signiﬁcant change correlation was
found when comparing examining the male group alone only; OD:
CA1, p ¼ 0.828; CA3, p ¼ 0.794; DG, p ¼ 0.777; PSA: CA1, p ¼ 0.662;
CA3, p ¼ 0.163; DG, p ¼ 0.427). In the female group however, PSA of
GR-ir was found to decline signiﬁcantly with age in the DG but not
in one of the other subregions, OD was not affected in the DG nor in
the CA subregions; (OD: CA1, p ¼ 0.171; CA3, p ¼ 0.970; DG,
p ¼ 0.076; PSA: CA1, p ¼ 0.055; CA3, p ¼ 0.366; DG, p ¼ 0.029.
4. Discussion
We demonstrate that GR protein is abundantly expressed
throughout the main neuronal subregions of the DG and CA of the
human hippocampus, and in approximately 50% of the astrocytes.
This distribution pattern is comparable with the rodent hippo-
campus and differs from that of the rhesus monkey, where very low
levels of GR were reported before (Sanchez et al., 2000). PMD was
shown not to affect these data, neither in a correlative study in the
human hippocampus, nor in an experimental study in the rat.
We further validated our antibody on Western blot, and the
slightly lowermolecularweight foundwith theGRa antibody E-20 is
consistent with a previous molecular study conﬁrming that, in
addition to the archetypal full-length 94 kDa receptor, multiple true
GRa variants exist in vivo. Irrespective of possible posttranslational
modiﬁcation, the predominant isoform in human brain tissue was
the67kDa isoform, regardlessof theanti-GRaantibodyused(Sinclair
et al., 2011). Also, this variant follows the same developmentalpattern as the full length GRa-A form (Sinclair et al., 2011). Second,
preabsorption tests resulted in the expected absence of staining.
Finally, high GR expression was expected and indeed selectively
observed in theCRH-producing,parvocellular, butnotmagnocellular,
neurons in the hypothalamic PVN. This strongly supports that the
antibody indeed identiﬁes GR in the human hippocampus.
Our new protein distribution data are consistent with previous
papers demonstrating prominent expression of mRNA for the GR in
the human hippocampus (Alt et al., 2010; DeRijk et al., 2003; Klok
et al., 2011a; Lopez et al., 1998; McGowan et al., 2009; Turner and
Muller, 2005; Watzka et al., 2000; Webster et al., 2002). Also with
in situ hybridization, abundant GR mRNA was found in the human
DG and CA subﬁelds (Lopez et al., 1998; Noorlander et al., 2006;
Seckl et al., 1991, 1993; Wetzel et al., 1995).
Clear differences have been reported in various structural,
metabolic, or functional parameters over the septotemporal or
horizontal axis of the hippocampus, for example, using high-
resolution positron emission tomography/magnetic resonance
imaging (Cho et al., 2011), magnetic resonance spectroscopy (King
et al., 2008), N-methyl-D-aspartate/a-amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid (NMDA/AMPA) receptor distribution
(Pandis et al., 2006), or electrophysiological readouts (Maggio and
Segal, 2009), and in terms of disease vulnerability or synaptic
connectivity, the hippocampus also shows anatomic differences
(Ta et al., 2012; Thom et al., 2012; Harrison and Eastwood, 2001). In
viewof thesegradients along the septotemporal axis,wealso studied
GR levels at more rostral and more caudal levels in an additional set
of patients, but did not ﬁnd major differences compared with our
measurements performed at themidlevel (see Supplementary data).
This indicates that GR protein is distributed in a homogenous way
along the entire septotemporal axis of the human hippocampus.
Another possible confound could be atrophy of the hippo-
campus that might occur with age. However, in a previous study,
such changes were reported to occur mostly in the head and tail of
the hippocampus (Pruessner et al., 2001) and because midlevels
were studied here, atrophy of the hippocampus should thus not
pose a major problem for our current results. However, the present
data are presented as densities and thus reﬂect changes in the total
amount of the (GR) protein in the various brain regions only to the
extent that the volumes of these regions do not change in volume
during aging.
Fig 5. Quantiﬁcation of hippocampal glucocorticoid receptor (GR)-immunoreactivity (ir) expressed as: total surface areas covered by the GR-ir (PSA, left series) and: averaged optical
density (OD, right series) and the correlations of both these GR-ir parameters with age, plotted for CA1, CA3, and dentate gyrus (DG).
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absent expression of GR protein, as was found in rhesus monkey
(Sanchez et al., 2000), would have been very surprising. Moreover,
a variety of experimental studies in humans have shown potent
effects on hippocampus- and GR-dependent cognitive functions,
conﬁrming the high sensitivity of the hippocampus to stress and
GCs (Cornelisse et al., 2011; Henckens et al., 2009; Khalili-Mahani
et al., 2010; Kumsta et al., 2010; Lovallo et al., 2010; Lupien et al.,
2007; Zobel et al., 2008).
Although the human hippocampus is clearly responsive to GCs
in functional terms, these effects are not necessarily mediated
through GRa alone. Various splice variants of GR not studied here,
might contribute as well (Alt et al., 2010; Kumsta et al., 2010;
Sinclair et al., 2011; Sinclair et al., 2012; Webster et al., 2002). The
rodent hippocampus is further enriched not only with GR but also
with high-afﬁnity mineralocorticoid receptors (MR) that are occu-
pied already at low levels of the stress hormone. Recent studies
have implicated MR in rapid, nongenomic effects on rat hippo-
campal neurons (de Kloet et al., 2008; Joels and Baram, 2009; Joels
et al., 2009), in structural plasticity (Gass et al., 2000), but also in
aspects of human HPA axis regulation, mood, and depression
(DeRijk et al., 2011; Klok et al., 2011a; Wang et al., 2008; Wickert
et al., 2000; Xing et al., 2004). So far, MR mRNA and protein have
been identiﬁed in human brain (Klok et al., 2011a, 2011b; Qi et al.,
2012; Xing et al., 2004), and also high MR mRNA levels have been
described in the hippocampal DG and CA2eCA3 of marmoset
(Johnson et al., 1996), squirrel (Patel et al., 2000), rhesus monkey
(Meyer et al., 1998, 2001; Sanchez et al., 2000), and in humans(Seckl et al., 1991; Wetzel et al., 1995). For MR and GR, the cDNA
sequence is conserved among New World monkeys and homology
with human MR and GR is high (Brandon et al., 1991; Patel et al.,
2000). Although beyond the scope of the present study, the ratio
between GR and MR might be important for age-related hippo-
campal changes and/or vulnerability for disease, and will be
important to consider in future studies (de Kloet et al., 2005; Qi
et al., 2012).
In previous reports, changes in HPA parameters or stress
responsivity have been associated with altered GR protein expres-
sion in the hippocampus (e.g., during age) (Herman and Spencer,
1998; Mizoguchi et al., 2009; Patel et al., 2008). For instance, in
Lewis rats, which exhibit HPA hypoactivity, high levels of GR
expression are present, whereas in the Fisher rat, the opposite is
found. Also, downregulation of the GR by stress has been observed
in monkeys (Meyer et al., 2001; Pryce, 2008). In human aging,
increases in cortisol levels and other HPA parameters have been
reported (Bao and Swaab, 2007; Conrad and Bimonte-Nelson, 2010;
Lupien et al., 1998; Raadsheer et al., 1993, 1994, 1995; Swaab et al.,
2005). Yet, the present data suggest that at least in the human
hippocampus, GR levels are generally not altered with age, except
for the age-associated decline in the DG of females. A general
stability of hippocampal GR expression during age was also re-
ported earlier at the mRNA level although increases were found in
the prefrontal cortex (Perlman et al., 2007). In addition, differential
patterns have been observed over the life span for the different GRa
variants (Sinclair et al. 2010). Additional postmortem studies on GR
mRNA expression in patients diagnosed with schizophrenia or
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hypercortisolemia, also failed to show a reduction in hippocampal
GR mRNA level.
Regarding the present reduction in GR protein expression in the
female DG with age, clear sex differences in cortisol level and CRH
expression have been reported before (Bao and Swaab 2007; Erkut
et al., 2004; Heuser et al., 1994; Wang et al., 2012). Androgens
selectively modulate GR, but not MR (Kerr et al., 1996) and older
women display stronger increases in salivary free cortisol than older
men (Bao et al., 2008; Seeman et al., 2001). In postmortem brain,
increased levels of GR mRNAwere reported in the cortex of females
compared with males, but no sex differences were reported in the
hippocampus. This was however measured in hippocampal
homogenates and hippocampal subregions were not distinguished
(Watzka et al., 2000). Clearly, sex differences need to be taken into
account when investigating levels of hormones and their receptors,
evenwith rare human material.
In addition to the current GR expression in neuronal nuclei, GR
was expressed in approximately 50% of the astroglial cells in the
human CA, hilus, and cortex, with lower levels in the DG. In
previous studies in rats, glia cells were shown to express both GR
and MR, and to be capable of responding to steroid exposure (Bohn
et al., 1991; Cintra et al., 1994). We show that also in humans, GR is
expressed in a considerable proportion of astrogliawhich can hence
form a relevant substrate for mediating glucocorticoid responsivity.
Functionally, GCs might impair the ability of astrocytes to aid
neurons (e.g., by impairing their ability to buffer glutamate from the
synapse; Virgin et al., 1991). Glial deﬁcits have been reported in the
prefrontal cortex (PFC) after stress, and stress also affected astro-
cyte number in tree shrews (Czeh et al., 2006; Stockmeier et al.,
2004). Possibly, such glia changes could contribute to hippo-
campal volume reductions as well (Czeh and Lucassen, 2007).
The low GR expression in the hippocampus of rhesus monkeys
(Sanchez et al., 2000) was in contrast to the strong GR expression in
the hippocampus of rodents (Fuxe et al., 1985; Morimoto et al.,
1996; Sarabdjitsingh et al., 2009; Van Eekelen et al., 1988) and
other mammals (Pryce, 2008), like guinea pig, pig (Weaver et al.,
2000), marmoset (Pryce et al., 2005), squirrel monkey (Patel
et al., 2000), and tree shrews (Meyer et al., 1998, 2001). Because
much research on stress or glucocorticoid actions on the brain is
performed in rodents, the low GR expression levels in this partic-
ular primate (Sanchez et al., 2000) suggested at the time that if
similar low densities of GR were present also in the human
hippocampus, this might have considerable relevance for the
extrapolation of ﬁndings on GCs in rodents to similar actions and
stress-related pathologies in humans.
Although beyond the scope of the present report, it remains
unclear why the hippocampus of the rhesus monkey would
contain low GR levels because several studies in other nonrodent
or primate species have shown prominent expression of GR in the
hippocampus (Johnson et al., 1996; Meyer et al., 1998; Patel et al.,
2000, 2008; Pryce et al., 2005), suggesting that the rhesus monkey
is indeed an exception in this respect. One explanation could be
that this pattern is unique and that in this particular primate,
neocortical and hypothalamic areas, that did express high GR
levels (Sanchez et al., 2000), might be more important glucocor-
ticoid targets than the hippocampus. Another possibility is that
similar to other monkey studies, previous (early life) stress inﬂu-
enced GR levels in this particular study (Arabadzisz et al., 2010;
Meyer et al., 2001; Patel et al., 2008). In humans, adverse early
life events such as childhood abuse have been shown to affect
human GR expression and HPA function and to form important
risk factors for HPA regulation, structural alterations, and depres-
sion during adult life (McGowan et al., 2009; Oberlander et al.,
2008; Wang et al., 2012).In summary, high level of GRa protein are present in human
hippocampal neurons and glia throughout the DG and CA subﬁelds.
This indicates that the human hippocampus can be sensitive to GC
exposure, consistent with a variety of effects of GC or stress expo-
sure on human hippocampal cognitive functions.
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